The FDA has granted approval for AbbVie’s 15mg Rinvoq (upadacitinib) to treat adults with giant cell arteritis (GCA).

Shares of AbbVie Inc. rose 3.38% to $192.34 Monday, on what proved to be an all-around great trading session for the stock ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

Shares of AbbVie Inc. ABBV advanced 1.88% to $180.37 Thursday, on what proved to be an all-around favorable trading session ...

Jeffrey Stewart; Executive Vice President, Chief Commercial Officer; AbbVie Inc Roopal Thakkar; Executive Vice President, Research & Development, Chief Scientific Officer; AbbVie Inc Scott Reents ...

AbbVie Inc (ABBV) surpasses expectations with robust sales growth in Skyrizi and Rinvoq, while navigating challenges in ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other Billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks that will always grow. Threats of an impending recession are looming over the stock m ...

AbbVie Inc.’s (NYSE:ABBV) year is off to a very strong start. The company beat Q1 2025 revenue and EPS estimates and raised the full-year EPS guidance range by $0.10 and the full-year revenue ...

NORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter profit of $1.29 billion. The North Chicago, Illinois-based company said it had net income of ...